Pressurized intraperitoneal aerosol chemotherapy (PIPAC)

PROCEDURE3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Prof. Aviram Nissan, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions

Cancer MetastaticChemotherapy EffectColon AdenocarcinomaGastric AdenocarcinomaMetastatic Colorectal CancerPeritoneal CarcinomatosisPeritoneal Metastases From Colorectal Cancer

Phase 2

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study

CompletedNCT04065139

Assistance Publique - Hôpitaux de ParisCancer Metastatic, Chemotherapy Effect, Gastric Adenocarcinoma

Start: 2020-06-11End: 2024-03-02Updated: 2024-09-19

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Prof. Aviram NissanColon Adenocarcinoma, Metastatic Colorectal Cancer, Peritoneal Carcinomatosis

Start: 2020-08-01End: 2023-08-01Target: 50Updated: 2020-07-17

Unknown Phase

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoPeritoneal Metastases From Colorectal Cancer

Start: 2021-04-30End: 2025-12-31Target: 10Updated: 2023-10-19